✦ LIBER ✦

One-year reduction of glucose metabolism in the olfactory tract in Alzheimer's disease

✍ Scribed by Imabayashi, Etsuko; Matsuda, Hiroshi; Tsutomu, Soma; Kuji, Ichiei; Ishii, Kenji; Ito, Kengo; Iwatsubo, Takeshi

Book ID: 121994360
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 352 KB
Volume: 9
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2013.05.1188

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pilot data on telmisartan short-term eff

Pilot data on telmisartan short-term effects on glucose metabolism in the olfactory tract in Alzheimer's disease

✍ Etsuko Imabayashi; Hiroshi Matsuda; Kimiko Yoshimaru; Ichiei Kuji; Akira Seto; Y 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 414 KB

Axonal loss from the olfactory tracts in

Axonal loss from the olfactory tracts in alzheimer's disease

✍ Davies, D.C.; Brooks, J.W.; Lewis, D.A. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 509 KB

Glucose metabolism in the temporal lobes

Glucose metabolism in the temporal lobes in Alzheimer's disease

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 178 KB

The metabolism of plasma glucose and cat

The metabolism of plasma glucose and catecholamines in Alzheimer's disease

✍ H Umegaki; N Tamaya; T Shinkai; A Iguchi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 329 KB

Coronal reconstruction images of glucose

Coronal reconstruction images of glucose metabolism in Alzheimer's disease

✍ Hidenao Fukuyama; Kiyoshi Harada; Hiroshi Yamauchi; Toshihiko Miyoshi; Shinya Ya 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 794 KB

Glucose metabolic rate and progression o

Glucose metabolic rate and progression of illness in Alzheimer's disease

✍ Benjamin V. Siegel Jr.; Monte S. Buchsbaum; Arnold Starr; Richard C. Mohs; Dirce 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 742 KB

## Abstract Thirty‐eight patients with mild to moderate Alzheimer's disease (AD) underwent a neuropsychological test battery and 18‐fluoro‐2‐deoxyglucose (FDG) positron emission tomography (PET) before beginning and at the end of a randomized double‐blind study of an experimental treatment. Twelve